| |
| |
|
| Insider
Information: |
Holmes Scott A |
| Relationship: |
Chief Financial Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
51,958 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$714,423 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
51,958 |
|
|
| Total
Value |
$714,423 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
SVP, Finance and Treas... |
2015-06-15 |
51,958 |
2012-09-12 |
0 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2018-12-12 |
0 |
2015-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(162,956) |
0 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-11-15 |
4 |
S |
$2.77 |
$3,199 |
D/D |
(1,155) |
162,956 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-10-29 |
4 |
S |
$3.07 |
$3,850 |
D/D |
(1,254) |
164,111 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-08-15 |
4 |
S |
$3.04 |
$3,602 |
D/D |
(1,185) |
165,365 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-07-30 |
4 |
S |
$3.86 |
$9,086 |
D/D |
(2,354) |
166,550 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-05-15 |
4 |
S |
$5.69 |
$6,589 |
D/D |
(1,158) |
168,904 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-04-30 |
4 |
S |
$4.67 |
$11,241 |
D/D |
(2,407) |
170,062 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
41,250 |
172,469 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-02-15 |
4 |
S |
$4.81 |
$27,181 |
D/D |
(5,651) |
131,219 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2018-01-29 |
4 |
S |
$4.81 |
$13,612 |
D/D |
(2,830) |
136,870 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-10-30 |
4 |
S |
$6.03 |
$15,569 |
D/D |
(2,582) |
139,700 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-07-31 |
4 |
S |
$7.14 |
$10,317 |
D/D |
(1,445) |
142,282 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-07-28 |
4 |
S |
$6.96 |
$8,603 |
D/D |
(1,236) |
143,727 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-05-01 |
4 |
S |
$5.97 |
$8,603 |
D/D |
(1,441) |
144,963 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-04-28 |
4 |
S |
$5.89 |
$7,180 |
D/D |
(1,219) |
146,404 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
147,623 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2017-01-30 |
4 |
S |
$4.65 |
$39,279 |
D/D |
(8,447) |
98,873 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2016-10-28 |
4 |
S |
$4.44 |
$5,492 |
D/D |
(1,237) |
107,320 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2016-07-29 |
4 |
S |
$7.36 |
$36,322 |
D/D |
(4,935) |
108,557 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
53,750 |
113,492 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-11-04 |
4 |
B |
$5.40 |
$7,171 |
D/D |
1,328 |
59,742 |
2.74 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-11-03 |
4 |
B |
$5.30 |
$19,458 |
D/D |
3,672 |
58,414 |
2.74 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-08-21 |
4 |
B |
$5.72 |
$28,590 |
D/D |
5,000 |
54,742 |
2.74 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-07-31 |
4 |
S |
$7.87 |
$21,705 |
D/D |
(2,758) |
49,742 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial OfficerOfficer |
• – – |
2015-07-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,500 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
